By proceeding, you agree to our Terms of Use and Privacy Policy.
Following the FDA’s announcement of ‘Alternative Methods Working Group’ in the summer, 2021, Roche’s newly opened pRED Innovation Center in Basel, and exciting data from Recce Pharma’s anti-infective candidate using organoids, the 7th Annual 3D Tissue Models Summit will return to Boston in May 2022 to reunite the community of drug discovery and dev
The event in Boston will reunite drug discovery and development experts to explore and integrate complex 3D models featuring 30+ real-life case studies.
In the event, hear how drug developers such as Origami Therapeutics adopt iPSC and other 3D cell culture and tissue models for their drug discovery.
Network with peers from Novartis, Merck, Sanofi and more to increase predictability of efficacy, pharmacology and biomarker identification.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Best in class in vitro models to accurately predict in vivo outcomes.
CELLINK is proud to be a part of BICO, the world’s leading bioconvergence company.
Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.
Curi Bio is accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data.
SCREEN Americas (Elk Grove Village, Illinois), a SCREEN Graphic and Precision Solutions group company, provides a wide range of solutions to meet graphic communications needs, with a strong focus on production-class inkjet printing technology.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.